Development of galectin-3 targeted radioimmunoligands for cancer theranostics.
- DOI
- 10.1016/j.apsb.2025.12.028
- Published
- 2026 Sep
- Container
- Acta pharmaceutica Sinica. B
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2025.12.028,
title = {Development of galectin-3 targeted radioimmunoligands for cancer theranostics.},
author = {Zhang S and Hu Q and Lu Q and Wu J and Li Z and Wan Y and Huang H and Chen X and Liu C and Tian H and Shen J and Jiang S and Zuo Q and Gao X and Cao Z and Yuan X and Cui B and Wang F and Wang J and Zhang MR and Li P and Lu N and Hu K},
year = {2026},
journal = {Acta pharmaceutica Sinica. B},
doi = {10.1016/j.apsb.2025.12.028},
url = {https://doi.org/10.1016/j.apsb.2025.12.028}
}RIS
TY - JOUR TI - Development of galectin-3 targeted radioimmunoligands for cancer theranostics. AU - Zhang S AU - Hu Q AU - Lu Q AU - Wu J AU - Li Z AU - Wan Y AU - Huang H AU - Chen X AU - Liu C AU - Tian H AU - Shen J AU - Jiang S AU - Zuo Q AU - Gao X AU - Cao Z AU - Yuan X AU - Cui B AU - Wang F AU - Wang J AU - Zhang MR AU - Li P AU - Lu N AU - Hu K PY - 2026 JO - Acta pharmaceutica Sinica. B DO - 10.1016/j.apsb.2025.12.028 UR - https://doi.org/10.1016/j.apsb.2025.12.028 ER -
APA
S, Z., Q, H., Q, L., J, W., Z, L., Y, W., H, H., X, C., C, L., H, T., J, S., S, J., Q, Z., X, G., Z, C., X, Y., B, C., F, W., J, W., MR, Z., P, L., N, L., & K, H. (2026). Development of galectin-3 targeted radioimmunoligands for cancer theranostics.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2025.12.028
Source records
- pubmed · retrieved 2026-09-25T19:44:27.318Z